A 41 year old man who worked at a PVC factory and had suffered from daily cough and gradually increasing dyspnoea since July 1981 has been followed since February 1982. He had smoked one package of cigarettes daily for 20 years.
The patient had worked in a PVC factory from 1974 but had an accumulated exposure to PVC dust of only about 750 days. Total dust concentrations during packing of PVC ranged from 0.3 to 42 mg/m3 (median of 38 measurements 2 mg/mi3). He had worked for a total of 60 days in the most dusty work phases. He had been exposed to relatively low concentrations (0-3 ppm) of vinyl chloride monomer (VCM). He had not been exposed to asbestos or other known fibrogenic agents. PVC had been considered harmless because of the large mean particle size given by the producer (20-200pm). When we examined dust samples from the workroom air by electron microscopy, however, most of the particles were smaller than I pm.
Subjectively, the patient's performance capacity had declined but his clinical condition was normal. of macrophages with some haemorrhage and an increase in elastic and collagenous fibres. In the broncho-alveolar lavage fluid 82% of the cells were macrophages, many resembling foreign body giant cells. Some ferruginous bodies were also seen.
Sudan IV stains polyvinyl chloride powder red after treatment with alcohol and acetone in ordinary paraffin sections. 9 The alveolar macrophages of our patient contained abundant Sudan positive particles. The particles stained dark blue in Epon sections after toluidine blue treatment (fig 1) . Electron microscopic examination showed that the particles were electron dense, which is in agreement with earlier findings.4 X ray microanalysis showed chlorine in addition to osmium in the particles (fig 2) , whereas in other parts of the cells only osmium was detected from the osmium tetroxide used as postfixative in Epon embedding. These observations suggest that the phagocytosed material was PVC dust.
The patient had since the spring of 1982 received bronchodilators, which had given him relief of symptoms, although no improvement in pulmonary function was detectable. In June 1983 treatment with prednisolone was started (60-15mg for three months). No clear effect was seen. The patient was provided with domiciliary oxygen in 1984, which gave him subjective relief.
Discussion
Epidemiological6 -8 and experimental studies3 ' suggest an association between exposure to PVC and pulmonary radiographic and histological changes. In most of these studies nõ severe fibrosis or impairment of lung function has been found. Our patient had severe dyspnoea and a substantial decrease in transfer factor (diffusing capacity). The clinical picture in previous case reports has varied from slight reduction in vital capacity2 to severe dyspnoea. ' It has been suggested that severe impairment of pulmonary function and especially of transfer factor is associated with exposure to VCM rather than to PVC dust.'0 Our patient, however, had been only minimally exposed to VCM. He was considerably disabled despite the fact that both the duration and the level of exposure had been moderate, whereas most of the previously described patients had been heavily exposed for long periods.
Several 
